Interest in outcome prediction in breast cancer has increased due to the
steadily growing number and effectiveness of available systemic adjuvant
An accurate prognostic
model may aid in assessing the risk for recurrence. This information may be of
value in the clinical decision-making on whether to use systemic adjuvant
therapy or not, and in selection of the type of systemic therapy.
The objective of the FinProg project is to provide models for individualized
outcome prediction in breast cancer.